Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report.
Yoshifumi HidakaTakaaki ArigamiYusaku OsakoRyosuke DesakiMasahiro HamanoueSonshin TakaoMari KirishimaTakao OhtsukaPublished in: World journal of surgical oncology (2022)
Conversion surgery following pembrolizumab monotherapy has a potential utility for the treatment of MSI-high gastric cancer.